SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-012492
Filing Date
2019-03-04
Accepted
2019-03-04 16:54:11
Documents
4
Period of Report
2019-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-5698_18k.htm 8-K 32246
2 EX-1.1 a19-5698_1ex1d1.htm EX-1.1 258921
3 EX-5.1 a19-5698_1ex5d1.htm EX-5.1 9829
4 EX-99.1 a19-5698_1ex99d1.htm EX-99.1 10394
  Complete submission text file 0001104659-19-012492.txt   312611
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 19654647
SIC: 2834 Pharmaceutical Preparations